Tapewire

Nasdaq · USD

RGEN

REPLIGEN CORP

Export transactions ↓
Tapewire entity
486
SEC CIK
0000730272
Parsed reports
388

Last 12 months

Inside the activity.

0 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202601
May 202600
Jun 202601
Jul 202601
Aug 202601
Sep 202604
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 01, 2021 Filed Sep 2, 2021 20:29 UTC SaleCommon Stock 239 $280.27 $66,984.53
Disclosure

SEC source: 0000899243-21-034897 · doc4.xml · nonDerivative · entry 2

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,141

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F2 · price: $280.27 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.90 to $280.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 20:29 UTC Exercise / conversionCommon Stock 3,459 $38.76 $134,070.84
Disclosure

SEC source: 0000899243-21-034897 · doc4.xml · nonDerivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,380

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

Read SEC document
August 30, 2021 Filed Sep 2, 2021 10:54 UTC
KURIYEL RALFSenior VP, R&D
SaleCommon Stock 4,001 $282.13 $1,128,802.13
Disclosure

SEC source: 0000899243-21-034834 · doc4.xml · nonDerivative · entry 1

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,354

F1 · price: $282.13 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.10 to $282.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 18, 2021 Filed Aug 19, 2021 20:42 UTC SaleCommon Stock 40 $262.31 $10,492.40
Disclosure

SEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 11

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,921

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

Read SEC document
August 18, 2021 Filed Aug 19, 2021 20:42 UTC SaleCommon Stock 78 $260.91 $20,350.98
Disclosure

SEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 10

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,961

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F10 · price: $260.91 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.80 to $261.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 18, 2021 Filed Aug 19, 2021 20:42 UTC SaleCommon Stock 388 $259.93 $100,852.84
Disclosure

SEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 9

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,039

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F9 · price: $259.93 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.39 to $260.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 18, 2021 Filed Aug 19, 2021 20:42 UTC SaleCommon Stock 634 $258.91 $164,148.94
Disclosure

SEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 8

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,427

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F8 · price: $258.91 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.32 to $259.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 18, 2021 Filed Aug 19, 2021 20:42 UTC SaleCommon Stock 302 $257.66 $77,813.32
Disclosure

SEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 7

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,061

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F7 · price: $257.66 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.14 to $258.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 17, 2021 Filed Aug 18, 2021 20:16 UTC
Hunt AnthonyDirector · Chief Executive Officer
GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-033450 · doc4.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,495

F1 · kind: The shares were disposed of in connection with a bona fide gift by the Reporting Person to a donor advised fund.

Read SEC document
August 17, 2021 Filed Aug 19, 2021 20:42 UTC SaleCommon Stock 194 $256.43 $49,747.42
Disclosure

SEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 6

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,363

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

Read SEC document
August 17, 2021 Filed Aug 19, 2021 20:42 UTC SaleCommon Stock 2,231 $255.07 $569,061.17
Disclosure

SEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 5

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,557

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F6 · price: $255.07 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.73 to $255.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 17, 2021 Filed Aug 19, 2021 20:42 UTC SaleCommon Stock 8,580 $254.09 $2,180,092.20
Disclosure

SEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 4

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,788

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F5 · price: $254.09 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.71 to $254.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 17, 2021 Filed Aug 19, 2021 20:42 UTC SaleCommon Stock 4,665 $253.34 $1,181,831.10
Disclosure

SEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 3

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,368

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F4 · price: $253.34 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.69 to $253.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 17, 2021 Filed Aug 19, 2021 20:42 UTC SaleCommon Stock 920 $251.92 $231,766.40
Disclosure

SEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 2

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,033

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F3 · price: $251.92 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.66 to $252.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 17, 2021 Filed Aug 19, 2021 20:42 UTC SaleCommon Stock 924 $251.15 $232,062.60
Disclosure

SEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,953

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F2 · price: $251.15 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.63 to $251.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 04, 2021 Filed Aug 5, 2021 23:33 UTC SaleCommon Stock 780 $250.50 $195,390.00
Disclosure

SEC source: 0000899243-21-031820 · doc4.xml · nonDerivative · entry 1

RYAN THOMAS F JR · CIK 0001263366 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 971

Read SEC document
July 20, 2021 Filed Jul 23, 2021 00:25 UTC SaleCommon Stock 614 $203.11 $124,709.54
Disclosure

SEC source: 0000899243-21-029561 · doc4.xml · nonDerivative · entry 4

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,877

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F5 · price: $203.11 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.78 to $203.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 20, 2021 Filed Jul 23, 2021 00:25 UTC SaleCommon Stock 2,877 $202.29 $581,988.33
Disclosure

SEC source: 0000899243-21-029561 · doc4.xml · nonDerivative · entry 3

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,491

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F4 · price: $202.29 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.76 to $202.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 20, 2021 Filed Jul 23, 2021 00:25 UTC SaleCommon Stock 806 $201.37 $162,304.22
Disclosure

SEC source: 0000899243-21-029561 · doc4.xml · nonDerivative · entry 2

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,368

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F3 · price: $201.37 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.76 to $201.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 20, 2021 Filed Jul 23, 2021 00:25 UTC SaleCommon Stock 288 $200.01 $57,602.88
Disclosure

SEC source: 0000899243-21-029561 · doc4.xml · nonDerivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,174

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F2 · price: $200.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.56 to $200.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 13, 2021 Filed Jul 15, 2021 21:17 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,929 $0.00 Strike: $41.19 $0.00
Disclosure

SEC source: 0000899243-21-028505 · doc4.xml · derivative · entry 3

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,929 shares

Expires 2025-07-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
July 13, 2021 Filed Jul 15, 2021 21:17 UTC SaleCommon Stock 1,520 $202.23 $307,389.60
Disclosure

SEC source: 0000899243-21-028505 · doc4.xml · nonDerivative · entry 2

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,462

F1 · price: $202.23 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.27 to $204.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 13, 2021 Filed Jul 15, 2021 21:17 UTC Exercise / conversionCommon Stock 2,929 $41.19 $120,645.51
Disclosure

SEC source: 0000899243-21-028505 · doc4.xml · nonDerivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,982

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 13, 2021 Filed Jul 22, 2021 22:53 UTC Amendment Exercise / conversionStock Option (Right to Buy) · Derivative 2,929 $0.00 Strike: $41.19 $0.00
Disclosure

SEC source: 0000899243-21-029533 · doc4a.xml · derivative · entry 6

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,929 shares

Expires 2025-07-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
July 13, 2021 Filed Jul 22, 2021 22:53 UTC Amendment SaleCommon Stock 5 $204.02 $1,020.10
Disclosure

SEC source: 0000899243-21-029533 · doc4a.xml · nonDerivative · entry 5

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,462

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F5 · price: $204.02 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.01 to $204.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 13, 2021 Filed Jul 22, 2021 22:53 UTC Amendment SaleCommon Stock 444 $203.09 $90,171.96
Disclosure

SEC source: 0000899243-21-029533 · doc4a.xml · nonDerivative · entry 4

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,467

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F4 · price: $203.09 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.86 to $203.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 13, 2021 Filed Jul 22, 2021 22:53 UTC Amendment SaleCommon Stock 630 $202.29 $127,442.70
Disclosure

SEC source: 0000899243-21-029533 · doc4a.xml · nonDerivative · entry 3

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,911

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F3 · price: $202.29 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.77 to $202.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 13, 2021 Filed Jul 22, 2021 22:53 UTC Amendment SaleCommon Stock 441 $201.27 $88,760.07
Disclosure

SEC source: 0000899243-21-029533 · doc4a.xml · nonDerivative · entry 2

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,541

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021.

F2 · price: $201.27 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.77 to $201.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 13, 2021 Filed Jul 22, 2021 22:53 UTC Amendment Exercise / conversionCommon Stock 2,929 $41.19 $120,645.51
Disclosure

SEC source: 0000899243-21-029533 · doc4a.xml · nonDerivative · entry 1

DAWES KAREN A · CIK 0001261506 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,982

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 22:48 UTC
KURIYEL RALFSenior VP, R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 1,045 $0.00 Strike: $86.10 $0.00
Disclosure

SEC source: 0000899243-21-023674 · doc4.xml · derivative · entry 5

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,092

Underlying: Common Stock · 1,045 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1,045 of the shares underlying the option have vested. The remaining shares vest as follows: 1,046 shares on February 27, 2022 and February 27, 2023.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 22:48 UTC
KURIYEL RALFSenior VP, R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 2,557 $0.00 Strike: $59.52 $0.00
Disclosure

SEC source: 0000899243-21-023674 · doc4.xml · derivative · entry 4

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,354

Underlying: Common Stock · 2,557 shares

Expires 2029-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 2,707 of the shares underlying the option have vested. The remaining 1,354 shares shall vest on February 28, 2022.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 22:48 UTC
KURIYEL RALFSenior VP, R&D
SaleCommon Stock 6,802 $189.19 $1,286,870.38
Disclosure

SEC source: 0000899243-21-023674 · doc4.xml · nonDerivative · entry 3

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,355

F1 · price: $189.19 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.70 to $189.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 22:48 UTC
KURIYEL RALFSenior VP, R&D
Exercise / conversionCommon Stock 1,045 $86.10 $89,974.50
Disclosure

SEC source: 0000899243-21-023674 · doc4.xml · nonDerivative · entry 2

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,157

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 10, 2021 Filed Jun 14, 2021 22:48 UTC
KURIYEL RALFSenior VP, R&D
Exercise / conversionCommon Stock 2,557 $59.52 $152,192.64
Disclosure

SEC source: 0000899243-21-023674 · doc4.xml · nonDerivative · entry 1

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,112

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 19, 2021 Filed May 21, 2021 01:00 UTC
Hunt AnthonyDirector · Chief Executive Officer
SaleCommon Stock 380 $175.15 $66,557.00
Disclosure

SEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 8

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,495

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020.

F9 · price: $175.15 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.98 to $175.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 19, 2021 Filed May 21, 2021 01:00 UTC
Hunt AnthonyDirector · Chief Executive Officer
SaleCommon Stock 2,819 $174.41 $491,661.79
Disclosure

SEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 7

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,875

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020.

F8 · price: $174.41 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.98 to $174.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 19, 2021 Filed May 21, 2021 01:00 UTC
Hunt AnthonyDirector · Chief Executive Officer
SaleCommon Stock 1,560 $173.19 $270,176.40
Disclosure

SEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 6

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,694

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020.

F7 · price: $173.19 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.96 to $173.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 19, 2021 Filed May 21, 2021 01:00 UTC
Hunt AnthonyDirector · Chief Executive Officer
SaleCommon Stock 3,036 $172.52 $523,770.72
Disclosure

SEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 5

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,254

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020.

F6 · price: $172.52 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.96 to $172.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 19, 2021 Filed May 21, 2021 01:00 UTC
Hunt AnthonyDirector · Chief Executive Officer
SaleCommon Stock 3,420 $171.32 $585,914.40
Disclosure

SEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 4

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,290

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020.

F5 · price: $171.32 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.93 to $171.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 19, 2021 Filed May 21, 2021 01:00 UTC
Hunt AnthonyDirector · Chief Executive Officer
SaleCommon Stock 7,911 $170.28 $1,347,085.08
Disclosure

SEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 3

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,710

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020.

F4 · price: $170.28 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.91 to $170.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 19, 2021 Filed May 21, 2021 01:00 UTC
Hunt AnthonyDirector · Chief Executive Officer
SaleCommon Stock 2,529 $169.45 $428,539.05
Disclosure

SEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 2

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,621

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020.

F3 · price: $169.45 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.90 to $169.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 19, 2021 Filed May 21, 2021 01:00 UTC
Hunt AnthonyDirector · Chief Executive Officer
SaleCommon Stock 612 $168.29 $102,993.48
Disclosure

SEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,150

F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020.

F2 · price: $168.29 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.61 to $168.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 14, 2021 Filed May 18, 2021 11:52 UTC
Gebski ChristineSee Remarks
SaleCommon Stock 445 $172.25 $76,651.25
Disclosure

SEC source: 0000899243-21-019723 · doc4.xml · nonDerivative · entry 1

Gebski Christine · CIK 0001849585 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,695

F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units.

F2 · price: $172.25 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.16 to $172.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 14, 2021 Filed May 18, 2021 11:50 UTC
KURIYEL RALFSenior VP, R&D
SaleCommon Stock 710 $172.29 $122,325.90
Disclosure

SEC source: 0000899243-21-019721 · doc4.xml · nonDerivative · entry 1

KURIYEL RALF · CIK 0001733143 · Senior VP, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,555

F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units.

F2 · price: $172.29 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.26 to $172.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 14, 2021 Filed May 18, 2021 11:49 UTC
Snodgres JonChief Financial Officer
SaleCommon Stock 470 $172.60 $81,122.00
Disclosure

SEC source: 0000899243-21-019720 · doc4.xml · nonDerivative · entry 1

Snodgres Jon · CIK 0001613498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,893

F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units.

F2 · price: $172.60 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.59 to $172.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 13, 2021 Filed May 18, 2021 01:59 UTC GrantStock Option (Right to Buy) · Derivative 1,151 $0.00 Strike: $169.65 $0.00
Disclosure

SEC source: 0000899243-21-019713 · doc4.xml · derivative · entry 2

EGLINTON MANNER CARRIE · CIK 0001696776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,151

Underlying: Common Stock · 1,151 shares

Expires 2031-05-13

F2 · derivative.exercise_date: Award vests in full on the earlier of May 13, 2022, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 13, 2021 Filed May 18, 2021 01:59 UTC GrantCommon Stock 457 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-019713 · doc4.xml · nonDerivative · entry 1

EGLINTON MANNER CARRIE · CIK 0001696776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 457

F1 · shares: Ms. Eglinton Manner was awarded 457 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 13, 2022, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 13, 2021 Filed May 18, 2021 01:57 UTC
MUIR GLENN PDirector
GrantStock Option (Right to Buy) · Derivative 1,151 $0.00 Strike: $169.65 $0.00
Disclosure

SEC source: 0000899243-21-019712 · doc4.xml · derivative · entry 2

MUIR GLENN P · CIK 0001181190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,151

Underlying: Common Stock · 1,151 shares

Expires 2031-05-13

F2 · derivative.exercise_date: Award vests in full on the earlier of May 13, 2022, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document
May 13, 2021 Filed May 18, 2021 01:57 UTC
MUIR GLENN PDirector
GrantCommon Stock 457 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-019712 · doc4.xml · nonDerivative · entry 1

MUIR GLENN P · CIK 0001181190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,362

F1 · shares: Mr. Muir was awarded 457 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 13, 2022, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

Read SEC document
May 13, 2021 Filed May 18, 2021 01:56 UTC GrantStock Option (Right to Buy) · Derivative 1,151 $0.00 Strike: $169.65 $0.00
Disclosure

SEC source: 0000899243-21-019710 · doc4.xml · derivative · entry 2

BARTHELEMY NICOLAS · CIK 0001283576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,151

Underlying: Common Stock · 1,151 shares

Expires 2031-05-13

F2 · derivative.exercise_date: Award vests in full on the earlier of May 13, 2022, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.